Diagnosis and Treatment of Tinea Corporis

Diagnostic Methods

• The British Journal of Dermatology recommends that specimens for potassium hydroxide (KOH) microscopy should be collected using a blunt scalpel to remove skin scale 2
• The British Journal of Dermatology states that KOH preparation typically shows hyphae and/or arthroconidia 3
• The British Journal of Dermatology suggests that fungal culture on Sabouraud agar with cycloheximide should be incubated for at least 2 weeks 3

Treatment

• The British Journal of Dermatology indicates that systemic antifungal treatment is necessary for immunocompromised patients with tinea corporis 4
• According to Pediatrics, itraconazole (100 mg daily) has shown superior efficacy (87% mycological cure rate) compared to griseofulvin (57% cure rate) when given for 15 days 5
• Pediatrics reports that terbinafine appears superior for infections caused by Trichophyton tonsurans 5

Monitoring and Follow-up

• Praxis Medical Insights recommends that the definitive endpoint for treatment should be mycological cure, not just clinical response 1
• The British Journal of Dermatology suggests that follow-up with repeat mycology sampling is recommended until mycological clearance is documented 4
• Praxis Medical Insights advises that treatment failure may require extending treatment duration or switching to an alternative antifungal 1

Prevention

• Praxis Medical Insights recommends covering lesions to prevent spread, and keeping affected areas clean and dry 1
• Pediatrics suggests that covering lesions can help prevent the spread of tinea corporis 5
• Praxis Medical Insights advises screening and treating family members if infection is caused by anthropophilic species 1

Common Pitfalls

• Praxis Medical Insights warns against stopping treatment too early based only on clinical improvement rather than mycological cure 1
• Praxis Medical Insights cautions against not considering secondary bacterial infection in inflammatory cases 1